Oxygenta Pharmaceutical Ltd — Board Meeting, 26-05-2025: Board Meeting

Oxygenta Pharmaceutical Limited has announced a board meeting on May 30 to approve the financial results for the quarter and half-year. The company has extended the trading window closure for designated persons and their immediate relatives until June 1, ensuring compliance with internal policies. This meeting and the subsequent results announcement are key for assessing the company’s recent financial performance and outlook.